Publications by authors named "Per Clauson"

Claim this Profile
C
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.
John Wilding, Thomas Godec, Kamlesh Khunti, Stuart Pocock, Robin Fox, Per Clauson

BMC Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial.
Yukiko Onishi, Yasuhiko Iwamoto, Soon Jib Yoo, Per Clauson, Søren C Tamer

J Diabetes Investig· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial.
Yasuhiko Iwamoto, Per Clauson, Tomoyuki Nishida, Kohei Kaku

J Diabetes Investig· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The once-daily human glucagon-like peptide-1 analog, liraglutide, improves β-cell function in Japanese patients with type 2 diabetes.
Yutaka Seino, Mads Frederik Rasmussen, Per Clauson, Kohei Kaku

J Diabetes Investig· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia.
Melanie J Davies, Tadeusz Derezinski, Claus Bang Pedersen, Per Clauson

Diabetes Technol Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of exercise on the absorption of inhaled human insulin in healthy volunteers.
Astrid H Petersen, Gerd Köhler, Stefan Korsatko, Andrea Wutte, Manfred Wonisch, Per Clauson

Br J Clin Pharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials.
Alan J Garber, Per Clauson, Claus B Pedersen, Klaus Kølendorf

J Am Geriatr Soc· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of exercise on the absorption of inhaled human insulin via the AERx insulin diabetes management system in people with type 1 diabetes.
Astrid H Petersen, Gerd Köhler, Stefan Korsatko, Andrea Wutte, Manfred Wonisch, Per Clauson

Diabetes Care· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education.
Diane Wild, Robyn von Maltzahn, Elaine Brohan, Torsten Christensen, Per Clauson

Patient Educ Couns· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index.
Katarina Raslová, Soren Can Tamer, Per Clauson, Diane Karl

Clin Drug Investig· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.
Astrid H Petersen, Torben Laursen, Bo Ahrén, Thomas R Pieber, Per Clauson

Eur J Pharm Sci· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.
Athena Philis-Tsimikas, Guillaume Charpentier, Per Clauson, Gabriela Martinez Ravn, Victor Lawrence Roberts

Clin Ther· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.
Kjeld Hermansen, Melanie Davies, Taudeusz Derezinski, Gabrielle Martinez Ravn, Per Clauson

Diabetes Care· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.
Aidan McElduff, Laurence E Mather, Peter C Kam, Per Clauson

Br J Clin Pharmacol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary insulin administration using the AERx insulin diabetes system.
John Thipphawong, Babatunde Otulana, Per Clauson, Jerry Okikawa, Stephen J Farr

Diabetes Technol Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis